Skip to content
Search

Latest Stories

Pharmacy First : 'Completely unreasonable to penalise pharmacies financially for the NHS’ failure,' says CPE CEO Janet Morrison

Pharmacy First : 'Completely unreasonable to penalise pharmacies financially for the NHS’ failure,' says CPE CEO Janet Morrison
Community Pharmacy England CEO Janet Morrison addresses challenges facing Pharmacy First, highlighting concerns over payment thresholds and the need for enhanced public engagement and support from NHS England

In a recent video update, Community Pharmacy England (CPE) CEO Janet Morrison addressed concerns among pharmacy owners regarding the Pharmacy First initiative, and the challenges it faces in achieving its goals, specially monthly payment thresholds.

Morrison highlighted the integral role of Pharmacy First in recognising the community pharmacy sector's significance in primary care:


“Pharmacy First is a critical service for community pharmacy: it is evidence of the growing recognition of the sector’s integral role in primary care, and it is a major clinical service development upon which others can be built."

"Community pharmacies have done an amazing job providing the service, despite the very tight implementation timeline and early battles with IT issues."

Morrison acknowledged the frustration among pharmacy owners regarding the ability to meet the monthly payment thresholds set by NHS England, citing concerns over the effectiveness of public outreach efforts:

“Frustratingly, the ability of pharmacy owners to reach the monthly payment thresholds is a major ongoing concern.

"Pharmacies are reliant on NHS England and the Department to drive people to the service, but following an underwhelming public marketing campaign, we don’t think we are seeing the numbers of walk-ins or referrals needed."

She pointed out that there are still uncertainties to be addressed, including the impact of seasonal fluctuations, and reaffirmed ongoing discussions with NHS England and the Department of Health and Social Care (DHSC) to find solutions:

“Many questions remain – including about the full impact of seasonality – and we are working through these at pace with the NHS and Department.

"During the original negotiations on Pharmacy First we had to argue very strongly for the upfront and monthly payments and we will continue to stress to the new Government just how critical these payments are.

"It is completely unreasonable to penalise pharmacies financially for the NHS’ failure to drive public and general practice behaviour changes."

Morrison expressed optimism about ongoing negotiations, aiming to enhance the service's success and support:

"Discussions with the Department and NHS England are ongoing, looking to find solutions, as we all share an objective to make the service a success.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less